Company: BGLC
Filing Date: 2025-07-30
Form Type: 8-K
Source: 0001477932-25-005322
Chunk: 1

Company: BioNexus Gene Lab Corp
Filing Date: 2025-07-30
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statement and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                                                                                                          
         99.1      Press Release dated July 30, 2025, titled “ BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance— Touted as a new ‘ DeepSeek Moment’ in Precision Oncology.”  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                                          

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BioNexus Gene Lab Corp.

             /s/ Su-Leng Tan Lee      
  By:        Su-Leng Tan Lee          
             Chief Executive Officer  
  Date:      July 30, 2025            

   3